US Stock News
Okta Shares Surge After Hours on AI-Driven Guidance Raise
Okta (NASDAQ: OKTA), the identity security software provider, saw its shares jump sharply in after-hours trading on Wednesday after beating second-quarter earnings estimates and raising full-year guidance for the second straight quarter.The
Nvidia Reportedly Agrees $12.9bn Deal for Hugging Face
Nvidia (NASDAQ: NVDA), the designer of GPUs and AI computing platforms, has agreed to buy open-source AI hub Hugging Face for $12.9bn, The Information reported, citing a single unnamed source. Neither company has confirmed the deal.NVDA sha
Boston Scientific Shares Slide After Cyberattack Halts Order Processing
Boston Scientific Corporation (NYSE: BSX), the Marlborough, Massachusetts-based maker of pacemakers, defibrillators and the WATCHMAN heart implant, saw its shares fall sharply after disclosing a cyberattack that has disrupted its ability to proces
Salesforce Shares Jump After Q2 Beat and Anthropic Tie-Up
Salesforce (NYSE: CRM), the customer relationship management software group, saw its shares jump roughly 11 to 12% in after-hours trading after second-quarter results comfortably beat Wall Street forecasts and management raised full-year guidance.
CrowdStrike Shares Jump After Record Quarter and Raised Outlook
CrowdStrike Holdings (NASDAQ: CRWD), the cybersecurity group behind the cloud-native Falcon platform, posted the strongest quarter in its history after Wednesday's close. Shares jumped roughly 10% in after-hours trading, CNBC reported, as investor
Snap Shares Sink After Pennsylvania Sues Snapchat Over Teen Safety
Snap Inc. (NYSE: SNAP) stock plunged as much as 9.9% on Wednesday, August 26, 2026, sliding to around $5.34 a share, after Pennsylvania Attorney General Dave Sunday filed a lawsuit against the company late Tuesday alleging Sn
Summit Therapeutics Shares Surge on Positive Phase III Data From Chinese Partner Akeso
Summit Therapeutics Inc. (NASDAQ: SMMT) shares jumped nearly 8% on Wednesday, August 26, 2026, rising to around $14.40 after its Chinese partner, Akeso Inc., announced positive topline results from a Phase III cancer trial in
Abercrombie & Fitch Shares Surge 37% on Tariff-Refund-Fuelled Earnings Beat
Abercrombie & Fitch Co. (NYSE: ANF), the teen and young-adult clothing retailer behind the Abercrombie and Hollister brands, saw its shares surge as much as 37% today after second-quarter results smashed analyst forecasts and the company raised it
Meta Shares Pare Gains After $16.7bn Teen-Safety Settlement
Meta Platforms (NASDAQ: META), the owner of Facebook, Instagram, Messenger and WhatsApp, agreed to pay up to $16.7bn to settle a lawsuit brought by a coalition of state attorneys general over allegedly addictive design and child-safety failures on
Intuit Stock Tumbles in After-Hours Trading Despite Q4 Earnings Beat
Shares of Intuit Inc. (NASDAQ: INTU) plunged more than 7% in after-hours trading Tuesday, August 25, 2026, after the financial-software giant issued disappointing fiscal 2027 guidance that overshadowed better-than-expected fo
Scotiabank Shares Surge on Record Quarterly Profit, Above-Target Returns
Shares of Bank of Nova Scotia (TSX/NYSE: BNS) rallied sharply on Tuesday, August 25, 2026, jumping as much as 5-7% intraday after the Toronto-based lender posted record fiscal third-quarter results that comfortably beat Wall
Why Dick’s Sporting Goods Stock Plummeted on Tuesday
Shares of Dick's Sporting Goods (NYSE: DKS) plunged as much as 25% on Tuesday, August 25, 2026, after the sporting goods retailer posted disappointing second-quarter results and slashed its full-year guidance, rattling invest
Shell Draws Exxon, LyondellBasell Interest in U.S. Chemicals Sale
Shell (NYSE: SHEL) (LON: SHEL) has attracted takeover interest from rivals ExxonMobil (NYSE: XOM) and LyondellBasell (NYSE: LYB) for a swath of its underperforming U.S. chemicals assets, according to a report from the Financi
Morgan Stanley Starts Rio Tinto Shares at Underweight, Sees Capped Capital Returns
Rio Tinto's (NYSE: RIO) U.S.-listed shares dipped on Monday after Morgan Stanley initiated coverage with an Underweight rating and a $90 price target, arguing the mining giant's risk/reward profile has become less compelling.
Aggreko to File for US Listing at Around $20 Billion Valuation – Sky News
Temporary power supplier Aggreko is preparing to file for a New York stock market listing that could value the company at around $20 billion, or £14.7 billion, according to Sky News.
Nvidia, Salesforce, Intuit Headline Earnings Week – Here’s What to Expect
Wall Street's attention turns to a trio of tech heavyweights this week, with Nvidia, Salesforce and Intuit all reporting quarterly results starting Monday, August 24, 2026. [s
Crypto Stocks Surge as Bitcoin Blasts Past $72,000
Shares of major cryptocurrency-linked companies rallied sharply Thursday as bitcoin surged above $72,000, its steepest one-day gain in months, igniting a broad risk-on move across digital-asset equities.
Here’s Why Tempus AI Stock Jumped on Wednesday
Shares of Tempus AI (NASDAQ: TEM) surged as much as 21% on Wednesday, August 19, 2026, rocketing from a previous close of $49.36 to an intraday high of $61.40 on volume of more than 13.5 million shares — over four times the s
Why Moderna Stock Has Rocketed on Wednesday
Moderna (NASDAQ: MRNA) shares skyrocketed more than 145% on Wednesday, touching a high of $163.43, after the company and partner Merck (NYSE: MRK) announced that their experimental mRNA-based melanoma vaccine met its main goa
Why Amylyx Pharmaceuticals (AMLX) Stock Soared on Tuesday
Shares of Amylyx Pharmaceuticals (NASDAQ: AMLX) skyrocketed on Tuesday, closing at $35.11 — up roughly 64% from Monday's close of $21.43 — as trading volume surged to nearly 23.8 million shares, almost 20 times its recent dai
Why Marvell Technology Stock Has Plunged Today
Shares of Marvell Technology (NASDAQ: MRVL) have so far tumbled 9.1% on Tuesday to $212.90 after opening at $220.52 and sliding as low as $212.18, as investors yanked money out of high-flying semiconductor and artificial-inte
Why argenx Stock Has Surged on Monday
Shares of argenx SE (NASDAQ: ARGX) rocketed higher on Monday, closing up roughly 16% at $990.80 after touching an intraday high near $998.82, as investors cheered positive Phase 3 trial results for the company's flagship drug
Anthropic’s IPO Valuation Rests on Bold $200 Billion Revenue Bet for 2028
Anthropic is preparing for what could rank among the largest IPOs on record, with Wall Street pricing the AI company based on a revenue forecast two years further out than investors typically consider,